Target intelligence / Profile preview

B cell receptors, T cell receptors, and antigen-presenting cell machinery

Molecular classification
Other
01

Overview

This entry describes a non-standard, combined grouping of immune targets rather than a singular, defined molecule or receptor. B cell receptor (BCR), T cell receptor (TCR), and antigen-presenting cell (APC) machinery are each distinct molecular entities or complexes with unique structure, function, and classification. - B cell receptor (BCR): A complex consisting of membrane-bound immunoglobulin and associated signaling subunits, mediating antigen recognition and signal transduction in B cells. - T cell receptor (TCR): Composed primarily of α and β (or γ and δ) chains, coupled to the CD3 complex, recognizing antigen-MHC complexes and transducing activation signals in T cells. - Antigen-presenting cell (APC) machinery: Refers collectively to the set of molecules used by professional APCs (such as MHC class I and II, co-stimulatory molecules like CD80/CD86), essential for antigen processing and presentation to T cells. Grouping these together is incorrect for target annotation, as each component is typically specified independently in therapeutic, biomarker, and mechanistic studies. The correct convention would require separately structured entries for "B cell receptor", "T cell receptor", and key "antigen-presenting cell" molecules such as "Major histocompatibility complex class II molecule" or "CD80". Summary of issues: This entry is not a canonical molecular target but a collection of functionally related immune molecules. Each subcomponent has unique structural and mechanistic properties, and should be annotated as a distinct target. The grouping leads to loss of specificity and prevents accurate mapping to drugs, mechanisms, and biomarkers. Some molecular actors within "APC machinery" are not receptors at all, but include enzymes, chaperones, and surface proteins. Recommendation: Divide this entry into: - "B cell receptor (BCR)" - "T cell receptor (TCR)" - Specific "antigen-presenting cell" molecules (e.g., "Major histocompatibility complex class II molecule", "CD80", "CD86", "CD40"). For structured annotation, process each entity individually, using canonical naming and molecular detail per your conventions.

02

Biological functions

Immune responseAntigen recognitionSignal transduction
03

Disease associations

CancerInfectionAutoimmune diseaseOther
04

Safety considerations

On-target/off-tumor activityImmune-related adverse effects

Beyond the preview

Go deeper on B cell receptors, T cell receptors, and antigen-presenting cell machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B cell receptors, T cell receptors, and antigen-presenting cell machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call